New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system First in the market, this unique service complements the Company’s T cell screening service Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing […]
DUBLIN, Ireland, and MILAN, Italy: ERS Genomics Limited (“ERS Genomics”), which was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Axxam S.p.A. (“Axxam”), a leading discovery biology company, today announced the signing of a license agreement granting Axxam access to ERS Genomics’ CRISPR-Cas9 patent portfolio, to support […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® CyTOF® technology was used in a clinical study producing preliminary evidence that mesenchymal stem cell (MSC) therapy improves outcomes in patients with COVID-19 pneumonia, providing key information about […]
BOSTON — NanoMosaic L.L.C. announced today it is commercializing technology for high-throughput, high-sensitivity analyte detection initially developed at Harvard University, through an exclusive license agreement with Harvard Office of Technology Development. NanoMosaic’s screening tools may aid in a number of biomedical fields including the early detection of disease, prognostic monitoring, biomarker discovery, and infectious disease […]
Back in September 2018, LGC acquired Lucigen Corporation. The ISO accredited site is based in Middleton, Wisconsin and employs just over 75 people. Lucigen specialises in enzymes, competent cells, and cloning systems to support applications in diagnostics, drug discovery, synthetic biology and gene editing, and now as a part of the Biosearch Technologies portfolio, is expanding […]
Specially developed research-grade PepTivator® Peptide Pools for SARS-CoV-2 BERGISCH GLADBACH – Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19. Based on decades worth of experience in developing products for virus-specific T cell research, SARS-CoV-2 PepTivator Peptide Pools work […]
LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe, announced it has signed a distribution agreement with abc biopply, an innovative and dynamic biotech company, to distribute abc biopply’s 3D CoSeedis™ cell culture technology in the Netherlands, Belgium and Luxembourg (Benelux), effective immediately. “We cannot wait to bring the novel 3D CoSeedis™ cell […]
WINOOSKI VT, USA — BioTek Instruments today introduced a new kit that can help researchers quickly obtain high-quality cell count results by automating the often tedious and error-prone process of mammalian cell counting. The new Cell Count & Viability Starter Kit automates cell counting and viability measurements in a mammalian cell suspension. When used with BioTek’s Cytation™ Cell […]
Robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis SCIEX, a global leader in life science analytical technologies, launched a new method for streamlining and improving the production of gene therapies. This innovative capillary electrophoretic method addresses a key customer challenge by analyzing AAVs to determine whether the therapeutic transgene […]
Expansion of marketing team to drive commercial launch of LX Genetic Analyzer BEVERLY, Mass. – LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today announced the appointment of Dr. Eleanor Kolossovski to the role of Director of Product Marketing. Dr. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
